Chinmaya Rath
Corporate Officer/Principal en GLYCOMIMETICS, INC. .
Fortuna: 43 679 $ al 31/05/2024
Cargos activos de Chinmaya Rath
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| GLYCOMIMETICS, INC. | Corporate Officer/Principal | - | - |
Catena Biosciences, Inc.
 Catena Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Catena Biosciences, Inc. is an American biotech company that was founded in May 2021. The company is based in El Cerrito, CA. The company is based on technology developed in the Doudna and Francis labs at the University of California, Berkeley. Catena Biosciences' patented technology, called the Catenase platform, allows the construction of biomolecules that are currently unobtainable using modern manufacturing techniques. The platform has applications across multiple therapeutic areas, with an initial focus in oncology. The company is the recipient of an NIH SBIR grant and the American Cancer Society's BrightEdge Golden Ticket at UC's Bakar Labs. The company was founded in 2020 by Marco Lobba, Gregorio Guillen, Matthew B. Francis. Marco Lobba has been the CEO since 2020. | Director/Miembro de la Junta | - | - |
| Cellurx | Director Ejecutivo | - | - |
| Fundador | - | - | |
Social Impact Capital, Inc.
 Social Impact Capital, Inc. Investment ManagersFinance Social Impact Capital LLC (Social Impact) is a Venture Capital firm founded in 2015 by Sarah Cone. The firm is headquartered in New York. | Inversor de Capital Privado | 01/11/2022 | - |
Historial de carrera de Chinmaya Rath
Formación de Chinmaya Rath.
| Warwick Business School | Masters Business Admin |
| Ravenshaw University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
| Reino Unido | 2 |
| India | 2 |
Operativa
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectorial
| Consumer Services | 3 |
| Health Technology | 2 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| GLYCOMIMETICS, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Catena Biosciences, Inc.
Catena Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Catena Biosciences, Inc. is an American biotech company that was founded in May 2021. The company is based in El Cerrito, CA. The company is based on technology developed in the Doudna and Francis labs at the University of California, Berkeley. Catena Biosciences' patented technology, called the Catenase platform, allows the construction of biomolecules that are currently unobtainable using modern manufacturing techniques. The platform has applications across multiple therapeutic areas, with an initial focus in oncology. The company is the recipient of an NIH SBIR grant and the American Cancer Society's BrightEdge Golden Ticket at UC's Bakar Labs. The company was founded in 2020 by Marco Lobba, Gregorio Guillen, Matthew B. Francis. Marco Lobba has been the CEO since 2020. | Commercial Services |
| Cellurx | |
Social Impact Capital, Inc.
Social Impact Capital, Inc. Investment ManagersFinance Social Impact Capital LLC (Social Impact) is a Venture Capital firm founded in 2015 by Sarah Cone. The firm is headquartered in New York. | Finance |
- Bolsa de valores
- Insiders
- Chinmaya Rath
- Experiencia
